# Rentschler Biopharma SE, Baden-Wurttemberg, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

> Inspection records and compliance data for Rentschler Biopharma SE in Baden-Wurttemberg. 10 FDA inspections on record, 3 Form 483s, last inspected May 05, 2023.

---

## Details

- Name: Rentschler Biopharma SE
- FEI Number: 1000291122
- Facility Type: Drug Substance Intermediate Manufacturer
- Address Line 1: Erwin-Rentschler-Str. 21
- Address Line 2: Laupheim
- City: Baden-Wurttemberg
- Country Name: Germany
- Address: Erwin-Rentschler-Str. 21 Laupheim, Baden-Wurttemberg, Germany
- Country: Germany

## Related Documents

- [FDA Inspection 1246782 - Rentschler Biopharma SE - 2023-05-05](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/0d912736-9230-4aef-96a6-874067c47f8c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 5, 2023
- [483 - Rentschler Biopharma SE - 2023-03-07](https://www.keypedia.com/records/483/rentschler-biopharma-se/a389d15c-79c7-4e86-8ab6-bab16b1db149) — source: FDA, date: March 7, 2023
- [FDA Inspection 1202157 - Rentschler Biopharma SE - 2023-03-07](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/300ac9e9-db9e-4c2e-a99e-94a03668b9ed) — source: FDA, date: March 7, 2023
- [483 - Rentschler Biopharma SE - 2022-02-15](https://www.keypedia.com/records/483/rentschler-biopharma-se/3d74a8dd-3407-4ca5-8531-86e86b20f52c) — source: FDA, date: February 15, 2022
- [EIR - Rentschler Biopharma SE - 2022-02-15](https://www.keypedia.com/records/eir/rentschler-biopharma-se/d3900ca0-3215-45e5-b136-19fb4ba548b9) — source: FDA, date: February 15, 2022
- FDA Inspection 1160831 - Rentschler Biopharma SE - 2021-02-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2021
- FDA Inspection 1102650 - Rentschler Biopharma SE - 2019-08-09 — classification: No Action Indicated (NAI), source: FDA, date: August 9, 2019
- FDA Inspection 1046488 - Rentschler Biopharma SE - 2018-03-08 — source: FDA, date: March 8, 2018
- [FDA Inspection 1022082 - Rentschler Biopharma SE - 2017-05-23](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/f2b2eb28-9fc0-4b27-a968-da94072cd325) — source: FDA, date: May 23, 2017
- [FDA Inspection 999800 - Rentschler Biopharma SE - 2016-12-06](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/fd3c2655-b57f-4166-9399-c3a17930da99) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2016
- FDA Inspection 933400 - Rentschler Biopharma SE - 2015-06-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2015
- FDA Inspection 853179 - Rentschler Biopharma SE - 2013-09-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2013
- FDA Inspection 744719 - Rentschler Biopharma SE - 2011-07-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2011

## Related Companies

- [Merz Pharma GmbH & Co., KGaA](https://www.keypedia.com/companies/merz-pharma-gmbh-co-kgaa/758203de-10f2-4cff-a0ca-d3b1152277c0)
- [Eriochem SA](https://www.keypedia.com/companies/eriochem-sa/e2f01909-c1a5-49e0-a736-041a0c65beba)
- [Sucampo Pharma, LLC](https://www.keypedia.com/companies/sucampo-pharma-llc/5a5bffc7-663f-47ab-8ccf-2078e2f49f60)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/4112e7fd-7d8d-41bc-914f-6c705b2e47c7)
- [Immunex Rhode Island Corporation](https://www.keypedia.com/companies/immunex-rhode-island-corporation/c70ebfcc-0c4d-4294-845a-24f1af8f30e9)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [Vistin Pharma AS avd Kragero Fikkjebakke](https://www.keypedia.com/companies/vistin-pharma-as-avd-kragero-fikkjebakke/6acc0a66-9192-481c-a1bf-4d4d0cbf68e7)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/86ee0564-73c3-4575-acbc-56fb8e87627c)
- [Asymchem Life Science (Tianjin) Co., Ltd.](https://www.keypedia.com/companies/asymchem-life-science-tianjin-co-ltd/ccb993d1-42a4-40fe-9c05-bf590f287eeb)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)

## Related Officers

- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)
- [Ralph M. Bernstein](https://www.keypedia.com/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [ Investigator, Consumer Safety Officer](https://www.keypedia.com/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [Caryn Mcnab](https://www.keypedia.com/people/caryn-mcnab/05d5f65d-5ab2-4798-a3a2-2798a82237e1)
- [Leiryn Boone](https://www.keypedia.com/people/leiryn-boone/be6ca3ec-68e0-41c6-a26b-09495fed0128)